WhatsApp Group Join Now
WhatsApp Channel Join Now
Telegram Group Join Now
HomeAR&DMSN Laboratories walk-in interview for Production, QC, AR&D, Microbiology, ESD on 9th...

MSN Laboratories walk-in interview for Production, QC, AR&D, Microbiology, ESD on 9th March 2024

MSN Laboratories Pvt. Ltd. is a rapidly growing manufacturer of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. The MSN Group consists of eight API manufacturing plants and a dedicated R&D Center. The company is experiencing a yearly growth rate of 30-40%. Our manufacturing facilities hold certifications such as ISO 9001-2000, WHO: GMP, EU: GMP, and USFDA approval. These plants are built following the core principles of Quality, Safety, and Environmental sustainability.

Exciting opportunity to work with MSN Laboratories Pvt Ltd, the fastest growing pharma company in India. Attend the walk-in interview on 9th March 2024 at Kardanur, Patanucheru, Telangana. Positions available in Production, Quality Control, and Engineering services. See qualifications required.

Walkin interview @ MSN Laboratories Pvt Ltd on 9th March 2024

Production (API)

  • Experience: 02 – 08 years
  • Qualification: B.Sc , B.Com & B A
  • Oncology experience added advantage

Quality Control (API)

  • Experience: 02-07 Years
  • Qualification: M.Sc (Organic /Analytical chemistry)/ B. Pharmacy & M.Pharmacy

Engineering services (API)

  • Experience: 02-10 Years (Pharma experience mandatory)
  • Qualification: Diploma/ITI
  • Roles & Responsibilities: Fitter – Shift Operations, Preventive maintenance activities, Breakdown maintenance

Work Location: MSN Laboratories Pvt Ltd, Unit -II Kardanur

Walk-in interview details
Date: 9th March 2024
Time: 9.30 am to 4.30 pm
Interview Venue: MSN Laboratories Pvt LTD, Unit -II Kardanur, Patanucheru Telangana

MSN Laboratories walk-in interview for Production, QC, AR&D, Microbiology, ESD on 9th March 2024

Exciting walk-in interview at MSN Laboratories for experienced candidates! Positions available in Production, CQC-AR&D, and Microbiology. Mark your calendar for 9th March 2024!

Walkin interview @ MSN Laboratories Pvt Ltd

Production (API)

  • Experience: 02 – 08 years of pharma API experience mandatory
  • Qualification: B.Sc. , B.Com & B A
  • Roles & Responsibilities: Handling of Reactors, Centrifuge, Driers, Powder processing equipment.

CQC – AR&D (API) 

  • Designation: Junior Executive/ Executive/ Senior Executive
  • Experience: 02 – 08 Years of pharma API experience
  • Qualification: M.Sc organic /Analytical chemistry/B.Pharmcy & M.Pharmacy
  • Role & Responsibilities:
    • Analysis of Raw Material, Stability samples and Finished products like Oral Solids & Liquids.
    • Handling investigations, Deviation, OOT,OOS.
    • Method Validations
    • Analytical Validations

Microbiology (API)

  • Designation: Executive/ Senior Executive
  • Experience: 2-8 Years of Pharma API Experience Mandatory.
  • Qualification: M.Sc Microbiology
  • Role & Responsibilities
      • Must have hands on experience in MLT and BET Analysis
      • Hands on experience in Media Preparation and Method Validations of MLT & BET
      • Hands on experience in Environmental Monitoring

Work Location: MSN Laboratories Pvt Ltd, Unit -I Rudraram

Benefits

  • Night shift allowance.
  • Free Transportation.
  • Subsidized Canteen

Walk-in Interview details

Date: 9th March 2024

Time: 9.30 am to 2.30 pm

Interview Venue: MSN Laboratories Pvt LTD, Unit -I Rudraram, Sangareddy Telangana

MSN Laboratories walk-in interview for Production, QC, AR&D, Microbiology, ESD on 9th March 2024

MSN Laboratories walk-in interview for Production, QC, AR&D, Microbiology, ESD on 9th March 2024

0/5 (0 Reviews)

Discover more from Pharma Walks

Subscribe to get the latest posts sent to your email.

RELATED JOBS

Join us

3,654FansLike
5,353FollowersFollow
4,233FollowersFollow
9,843SubscribersSubscribe

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Discover more from Pharma Walks

Subscribe now to keep reading and get access to the full archive.

Continue reading